ImpriMed

ImpriMed is a biotechnology company that uses artificial intelligence to help healthcare providers predict drug responses for cancer patients

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

Category Tags

AI Cancer Treatment for Dogs, Personalized Medicine for Pets, Canine Chemotherapy Predictions

About Us

ImpriMed uses artificial intelligence to predict the effectiveness of anticancer drugs for dogs with lymphoma or leukemia. By analyzing live cancer cells, they provide personalized treatment options, helping veterinarians choose the most effective chemotherapy for each dog.

Trending Companies in AI

Latest Articles in AI

Up to 63% off Anycubic 9th Anniversary Sale

CREATORS. DISRUPTORS. INNOVATORS.

Discover Emerging Technology Companies